Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Clinical trial NCT04452097 · WITHDRAWN

Trial details

NCT number: NCT04452097
Sponsor: Baylx Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 ARDS Acute Respiratory Distress Syndrome

Start date: 2026-06-01
Primary completion: 2027-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.